Combined third, fourth, and sixth nerve palsies …

Neuro-Ophthalmology & Neuro-Otology

Updated 07.17.2024
Released 01.08.2003
Expires For CME 07.17.2027

Combined third, fourth, and sixth nerve palsies

Authors: Ricky Paramo BS, Lakshmi Leishangthem MD

See Contributor Disclosures

Editor: Jonathan D Trobe MD

Combined third, fourth, and sixth nerve palsies

In This Article

Quick Link

Introduction

Overview

Patients complaining of diplopia may have signs that indicate involvement of multiple ocular motor nerve palsies. These must be differentiated from single ocular motor nerve palsies, neuromuscular junction, myopathic disorders, and supranuclear disorders. Their recognition is important because the differential diagnosis includes a higher frequency of mass and inflammatory lesions in the vicinity of the orbital apex or cavernous sinus, which may require urgent therapy.

Key points

	• Multiple ocular motor nerve palsies (combined third, fourth, or sixth nerve palsies) produce clinical manifestations that must be distinguished from extraocular muscle dysfunction, myasthenia gravis, and brainstem syndromes.
	• Cavernous sinus lesions are responsible for most multiple ocular motor palsies; they often also cause Horner syndrome and trigeminal neuropathy affecting the first two divisions.
	• Cavernous sinus lesions often extend into the orbital apex to cause an ipsilateral optic neuropathy.

Historical note and terminology

Multiple ocular motor palsies are present when ocular ductional deficits, with or without anisocoria and ptosis, lie in the domain of more than one ocular motor nerve. The manifestations may be unilateral or bilateral. The differential diagnosis includes lesions that arise in the brainstem, neuromuscular junction, or extraocular muscles.

“Ocular motor nerves” refers to cranial nerves 3, 4, and 6. “Oculomotor nerve” refers to cranial nerve 3.

Clinical manifestations

Presentation and course

The cardinal symptom of ocular motor palsies is binocular diplopia, which disappears when either eye is occluded. The diplopia may consist of seeing the second image as displaced horizontally, vertically, or obliquely. Eliciting whether the image displacement has been static or progressive is helpful in diagnosis. That is, has the diplopia proceeded from intermittent to persistent since onset? Has it spread from being present in one position of gaze to more than one position of gaze? Has image separation increased, decreased, or remained stable?

Eye movement testing may reveal a reduced range of ocular ductions, but diplopia can be present even when ductions appear to be full. In that case, assessment must include measurement of ocular alignment with subjective or objective tests. Subjective tests include the red glass, Maddox-rod, and Hess screen tests; objective tests include the cover test, alternate cover test, and prism-and-cover test.

The manifestations of a combination of complete third and sixth nerve palsy are not difficult to recognize. In addition to deficits in adduction, supraduction, and infraduction, there will be a deficit in abduction, as well as ptosis and often mydriasis. Incomplete palsies are more difficult to discern.

The combination of a third and fourth palsy is challenging to diagnose. In addition to the typical third nerve-related deficits, there will be a deficit in infraduction and intorsion, primarily when the eye is in the adducted position.

Discovering unilateral mydriasis is useful in excluding myopathic and neuromuscular junction disease (180). The addition of Horner syndrome (ipsilateral miosis and mild ptosis) suggests a lesion of the cavernous sinus. A caution here: third nerve palsy and Horner syndrome produce opposing effects on pupil size, so the combination of third nerve palsy and Horner syndrome may manifest with isocoria. The diagnosis is established by finding reduced constriction to light and a positive apraclonidine test.

Examination of facial sensation is critical as the V1 and V2 segments of the trigeminal nerve course near the ocular motor nerves in the middle cranial fossa. Multiple ocular motor palsies with facial numbness suggest a cavernous sinus lesion. Numbness limited to V1 can occur in an orbital apex lesion or an incomplete cavernous sinus lesion.

Ipsilateral headache and periocular pain are other common symptoms that suggest trigeminal nerve involvement in the orbit, superior orbital fissure, cavernous sinus, retrocavernous region, or floor of the middle cranial fossa.

Blurred vision may be due to mild diplopia if it goes away with covering either eye, or it may indicate optic nerve involvement caused by lesions of the optic nerve or optic chiasm.

Proptosis suggests an orbital mass or venous congestion from cavernous sinus or orbital apex pathology.

Prognosis and complications

The natural history of intracavernous carotid aneurysms can include either gradual improvement or worsening over months to years (103). Rarely, rupture of the aneurysm causes a high-flow carotid cavernous fistula (10). Subarachnoid hemorrhage is more likely when intracavernous aneurysms arise from the anterior genu of the carotid siphon or erode the sella turcica to extend intradurally (107; 102).

In high-flow carotid-cavernous fistula, vision may be lost immediately due to steal from the arterial supply to the optic nerve or retrograde venous flow into the orbit and an acute rise in intraocular pressure (54). Intracranial hemorrhage or epistaxis occurs in 10% of patients with high-flow carotid-cavernous fistula, causing death in 30% (54). Hemorrhage tends to occur within the first week but may be delayed up to 3 weeks. Retrograde venous flow may also extend toward the cerebrum to cause venous infarction (70). In low-flow carotid-cavernous fistula, bleeding and death are unlikely, but 30% have visual loss from high intraocular pressure (126; 54) or central retinal vein occlusion (91; 127). The combination of optic disc hyperemia, retinal vein dilation, and intra-retinal hemorrhage is touted as predictive of vision loss in carotid-cavernous fistula, with 75% visual impairment in high-flow fistula and 25% visual impairment in low-flow fistula (04).

In septic cavernous sinus thrombosis, death is nearly universal and rapid in untreated cases. There may be rapid progression over several days to bilateral ophthalmoplegia (30), systemic sepsis, meningitis, and brain abscess (181).

In idiopathic inflammation of the cavernous sinus or orbital apex region (Tolosa-Hunt syndrome), most patients never develop other neurologic or systemic defects (89), but there are rare reports of pituitary hypofunction, diabetes insipidus (63; Hama 1996; 179; 88), and thyroiditis (165; 83).

In herpes zoster infection of the cavernous sinus, there is usually substantial recovery, but it may take more than a year (141).

In SARS-CoV-2 infection, the ocular motor palsies typically resolve over a period of weeks to months, but deficits may persist (31).

Clinical vignette

A 56-year-old woman had pain for several weeks followed by oblique diplopia that became worse when she looked downward. When she was examined 3 weeks after the onset of diplopia, the pain was improving. She had a right hypertropia (worse in left gaze) and right head tilt, indicating a right fourth nerve palsy. Because of the pain, unusual for fourth nerve palsies, she underwent MRI and MRA, the results of which were normal. One month later, an examiner noted a right partial third nerve palsy in addition to the fourth nerve palsy. An intravenous edrophonium test was negative. One month later, an examination disclosed that the right eye had developed surface vascular congestion, mild proptosis, and a partial third and sixth palsy. She reported dysesthesia in the right V1 distribution, mainly over the vertex. A carotid-cavernous fistula was confirmed with imaging. MRI showed engorged extraocular muscles on the right. Lateral view of the digital angiogram showed rapid flow into the cavernous sinus and a dilated superior ophthalmic vein. She was treated with particle embolization. The clinical features regressed within days. Six months later, the only signs were a mild right sixth nerve palsy and Horner syndrome on the right.

Cavernous sinus and superior ophthalmic vein in pretreatment angiogram (lateral view)

Angiogram shows arterial blood entering the cavernous sinus and dilating the superior ophthalmic vein. (Contributed by Dr. Jason Barton.)
Fistula and superior ophthalmic vein (posttreatment angiogram)

Angiogram shows the material placed around the fistula as well as the disappearance of the blood in the superior ophthalmic vein. (Contributed by Dr. Jason Barton.)

Biological basis

Etiology and management

Inflammation and compressive lesions are the most likely causes of multiple ocular motor palsies. In several series, tumors accounted for 20% to 40% of unilateral third, fourth, and sixth nerve palsies (59; 129; 79). In other series, tumors accounted for 70% of cavernous sinus lesions (35% primary and 35% metastatic), and intracavernous aneurysms for 20% (158; 40; 113). Among 73 cases of cavernous sinus lesions from a tertiary care center in India, 29% of lesions were neoplastic, 25% were fungal, 23% were idiopathic inflammation (Tolosa-Hunt syndrome), 4% were infections, 7% other inflammatory, 7% vascular, and 2% diabetic (12).

Many lesions that cause cavernous sinus syndromes can also extend into the nearby orbital apex or be limited to that region. They differ from cavernous sinus lesions clinically by causing damage to the optic nerve and sparing the second trigeminal division (183; 159; 186).

Although brainstem lesions are rare causes of multiple ocular motor palsies, they must be considered, particularly if the ophthalmoplegia involves both eyes (24; Rush and Young 1981; 78; 133). Accompanying signs include ipsilateral limb ataxia, contralateral involuntary movements, contralateral hemiparesis, and ipsilateral facial nerve palsy.

Tumors. Among the tumors that cause multiple ocular motor nerve palsies are pituitary adenomas, schwannomas, meningiomas, craniopharyngiomas, and chondromas (113). Pituitary apoplexy is a medical emergency that can cause sudden involvement of one or both cavernous sinuses. Local spread from nasopharyngeal carcinoma is also a common cause, as are metastases from breast, lung, and prostate carcinoma (190; 18; 144). Metastatic colon carcinoma (117; 115) and hepatocellular carcinoma are rare causes (86; Carey and Sudhakar 2015). Lymphoma and multiple myeloma also occur. Primary tumors present more with painless and gradually progressive ophthalmoplegia, whereas metastatic tumors are more likely to have a subacute painful onset (158; 161; 113).

Aneurysms. Intracavernous aneurysms occur in older adults (107; 161; 151; 27). About 50% present with slowly progressive painless ophthalmoplegia, and the remainder present with acute pain and diplopia (161; 151). The sixth nerve is most commonly affected, followed by trigeminal pain or hypesthesia. The third nerve, fourth nerve, optic nerve, and oculosympathetic fibers may also be injured (161; 103; 151; 27).

Intracavernous aneurysms smaller than 12 mm in diameter can be observed through serial CT or MRI imaging (113). Reasons for intervention include epistaxis, subarachnoid hemorrhage, ophthalmoplegia progression, visual loss, or large aneurysm size (103). Treatment options include coil embolization or endovascular flow diversion (16; 113). Endovascular flow diversion has increased in popularity as it has been shown to decrease patient morbidity when compared to coil embolization (27).

The recovery of ocular motor nerve palsies from aneurysmal compression depends on the size of the aneurysm, the interval between the onset of palsy and surgery, and the degree of deficit (56; 152; 57; 77). Treatment within 2 weeks of palsy onset has a more favorable outcome than delayed intervention (46; 108). Recovery after compressive lesions may continue up to a year following treatment but may be complicated by aberrant regeneration (56; 57).

Fistulas. Carotid-cavernous fistulas occur frequently in the cavernous sinus and transverse sigmoid sinus. Patients may be asymptomatic, mildly symptomatic, or experience fatal hemorrhage. A case series of 40 patients over 11 years at a single institution reported 60% to have diplopia (72). Ophthalmic manifestations are present in 80% to 97% of patients (131). They are attributed to ischemia from the diversion of arterial blood supplying ocular motor nerves or from venous congestion.

Superior ophthalmic vein enlargement is a frequent finding on noninvasive imaging, but one publication reported that 27% of patients lacked this finding (72). Diagnosis is typically confirmed by digital angiography, as noninvasive imaging is often negative.

High-flow (“direct’) carotid-cavernous fistulas are arteriovenous shunts between the internal carotid artery and the cavernous sinus. Head trauma or spontaneous rupture of an intracavernous aneurysm is usually responsible (10; 62), but such fistulas may also arise after carotid endarterectomy (96; 118), trigeminal gangliolysis (94; 43), maxillofacial surgery (62), and inherited vascular defects such as Ehlers-Danlos type IV (143; 105) and fibromuscular dysplasia (65; 191). They present with sudden, severe, and painful pulsatile proptosis, periocular edema, and chemosis. Pulsatile tinnitus is often audible to the patient and to an examiner placing a stethoscope on the cheek, brow, temporal bone, or eye. Ocular motility is reduced either because of ocular motor palsies or orbital congestion. Fistulas that drain predominantly anteriorly into the orbit are more likely to produce ophthalmic manifestations than those that drain posteriorly, superiorly, or inferiorly.

Low-flow (“indirect,” “dural”) carotid-cavernous fistulas consist of arteriovenous shunts between dural branches of the internal or external carotid artery and the cavernous sinus. They occur spontaneously. Some 85% of patients are older than 55 years, and 90% are women (126; 10; 80; 66). They may rarely appear as congenital anomalies in infants (92; 52). A red eye develops over a few weeks with mild periocular pain, diplopia, and subtle proptosis (126; 122; 173), often mistaken for conjunctivitis. In addition to the ocular motor palsies, dilated scleral and conjunctival veins, slight exophthalmos, mildly increased intraocular pressure (126; 122), and secondary glaucoma (53; 84) have been reported. If the fistula drains posteriorly, orbital signs will be absent. Confusion and expressive aphasia may be seen if flow is directed toward the cerebrum (177).

In carotid-cavernous fistulas, urgent intervention is needed for progressive proptosis, visual loss, transient ischemic attacks, or angiographic signs of a cavernous sinus varix or cortical venous drainage (54). Endovascular intervention with coil embolization into the carotid defect is the preferred approach for direct fistulas. For dural low-flow fistulas, the options are observation, manual carotid compression, medications to lower intraocular pressure, and transvenous coiling (125; 05). Observation is preferred unless high-risk symptoms are present because up to 70% of all dural carotid-cavernous fistulas will close spontaneously (62). Treatment is indicated for visual loss, diplopia, pain, or exposure keratitis. High intraocular pressure is treated with medications or filtering procedures (126). If transvenous embolization cannot be performed, the alternative is using the transarterial approach to deposit glue or particles in the dural feeder vessels (169; 10; 62). The cavernous sinus can also be accessed via the superior ophthalmic vein or by direct transorbital puncture (125). Transvenous coil embolization is 80% effective in closing the fistula (109; 47; 125). Radiotherapy has been shown to result in complete remission 50% to 100% of the time (64; 120; 15).

Balloon embolization, formerly a common approach, is no longer practiced because complications occurred so frequently, including stroke, cranial nerve palsies, trigeminal sensory neuropathy, and intractable intraocular pressure elevation (101; 170; 67). Ehlers-Danlos syndrome has a 12% mortality and 36% morbidity rate for angiography (143), and fistula closure is challenging (55; 76). Novel approaches have included transvenous embolization via the superior ophthalmic vein (155).

Septic cavernous sinus thrombosis. This devastating condition occurs following infections of the midface, paranasal sinuses, orbit, teeth, and external or middle ear (30; 44). It may complicate minor head trauma (87), transsphenoidal craniotomy with CSF leakage (137), and cervical spinal fusion (44). In 65% of cases, the causal organism is Staphylococcus aureus. Streptococci (20%), pneumococci (5%), and anaerobic bacteria (5%) make up the remaining organisms (156; 181; 164; 112; 44).

For the management of septic cavernous sinus thrombosis, immediate intravenous broad-spectrum antibiotics are mandatory. If a fungal infection is suspected, amphotericin B should be added to the medication regimen (69; 44). The role of anticoagulation is unclear. Some suggest it may improve antibiotic access, remove clots that act as a culture media, and promote recanalization (156). But anticoagulation increases the risk of intracranial bleeding and hematogenous spread (181; 149; 100; 171; 44). It is contraindicated in patients with concomitant meningitis (100; 192; 166). In children with meningitis, there is no strong evidence against anticoagulation (140).

Among intensively treated patients, mortality is only 20% (181; 149; 30; 44). Only 10% to 15% of patients have lasting neurologic deficits (166). Late complications include ocular neuromyotonia (60), Korsakoff syndrome (13), and panhypopituitarism (124).

Idiopathic polycranial neuritis (Fisher syndrome). This condition consists of a triad of ophthalmoplegia, ataxia, and areflexia, sometimes following an upper respiratory or gastrointestinal tract infection by a few weeks (11). The pattern of ophthalmoparesis is highly variable. Spinal fluid examination usually discloses a moderately elevated protein with a normal cell count (“cytoalbuminous dissociation”), although 8% of patients may have a pleocytosis (11; 176). Nerve conduction studies can show absent sensory nerve action potentials, slowed motor or sensory conduction, or abnormal H and F wave latencies (74; 184; 03; 48; 75). However, normal conduction studies occur in up to 30% of cases (11; 07; 35). This condition is now considered an autoimmune antiganglioside antibody disorder. Serum autoantibodies to GQ1b-ganglioside are often positive, as they are in Bickerstaff brainstem encephalitis and acute ophthalmoplegia without ataxia (20; 19; 174; 42). Anti-GQ1b antibodies are also present in some patients with isolated acute or chronic bilateral partial ophthalmoplegia (153; 188).

Syphilis. Meningovascular syphilis (135; 154) and tuberculous pachymeningitis (98) are emerging causes of multiple ocular motor nerve palsies.

Fungal infection. Fungal infection is a rare cause of multiple ocular motor palsies (38). Aspergillus is the most common organism, followed by mucormycosis and coccidioidomycosis (44). Mucormycosis is encountered mainly in patients with diabetes mellitus, whereas aspergillosis and coccidioidomycosis are more often seen in patients with chronic renal failure, chronic myelocytic leukemia, SARS-CoV-2 infection (36) and other conditions associated with immunosuppression (145; 163; 44). Fungi spread from the sinuses or palate to the orbital apex and cavernous sinus. Early visual loss and retinal arterial occlusion are common (01; 123). A black necrotic crust of the nasal or palatal mucosa or black orbital pus suggests mucormycosis (99; 157).

Aggressive treatment is warranted, particularly because of the risk of septic arterial occlusion resulting in cavernous sinus thrombosis (61), hemorrhage (145), or mycotic aneurysm formation (121). Medication and surgical debridement of necrotic tissue are first-line therapies (69). Amphotericin B alone is likely to fail but may be more effective when combined with flucytosine and possibly rifampin. Wide surgical excision is recommended but frequently not feasible. Ethmoidectomy, sphenoidotomy, maxillary antrostomy, or orbital decompression may be required, depending on the extent of fungal spread (69).

As fungi become more resistant to pharmaceuticals, mortality continues to increase. Amphotericin B treatment formerly reduced mortality in mucormycosis from 90% to 15% (99). However, in a modern case series in which 53% of patients had cavernous sinus or orbital apex involvement and all received aggressive antifungal and surgical treatment, mortality was 50% (95).

Tolosa-Hunt syndrome. Idiopathic cavernous sinus or orbital apex inflammation (Tolosa-Hunt syndrome) presents at any age with acute painful ophthalmoplegia, sometimes with nausea and vomiting lasting days to weeks (89). Most commonly, the third and sixth cranial nerves are involved. The optic nerve is affected in 20% of cases, and there is second division trigeminal sensory loss in 10% (89). Horner syndrome, third-division trigeminal sensory loss, and seventh nerve palsy are other features (89; 162). Proptosis, chemosis, and periocular edema are rare. Pathology shows noncaseating granulomatous inflammation (45). Some cases may represent a localized form of granulomatosis with polyangiitis (110). This condition has also been associated with systemic lupus erythematosus (185), sarcoidosis (14), SARS-CoV-2 infection (22), and tuberculosis (142).

For management of Tolosa-Hunt syndrome, corticosteroids are the mainstay of therapy. However, the response is not diagnostic because steroids can improve signs in neoplasia, infections, and aneurysms (158; 41; 32; 25; 146). Successful clinical remission of recurrent Tolosa-Hunt syndrome was noted after treatment with corticosteroids followed by methotrexate (97). Adalimumab, a TNF inhibitor, also appears to be an effective treatment for corticosteroid-dependent disease (172).

In Tolosa-Hunt syndrome, pain responds within 48 to 72 hours of starting either oral or intravenous corticosteroids, mainly methylprednisone and dexamethasone (148; 85). Recovery from cranial nerve palsy takes 2 to 8 weeks (58). The prognosis for complete recovery from a single attack is favorable (32), but a few patients can have residual ocular motor paresis. Painful ophthalmoplegia recurs ipsilaterally or contralaterally in 20% to 40% of patients at intervals varying from months to years. In three studies, patients who received corticosteroid-sparing agents had a significantly lower recurrence rate (58; 08; 85).

SARS-CoV-2 infection. Cranial nerve palsies have appeared in conjunction with respiratory symptoms or, rarely, as isolated findings in patients with COVID-19 infection (29; 167). The SARS-CoV-2 virus causes hyperstimulation of the immune system, which results in the overproduction of autologous antibodies in genetically predisposed patients. Additionally, heptapeptide sharing exists between SARS-CoV-2 spike glycoproteins and mammalian proteins, suggesting that molecular mimicry may play a part in the stimulation of secondary autoimmune conditions (33). Typically, the ocular motor cranial nerve palsies of SARS-CoV-2 spontaneously resolve within 1 month of onset (31).

Herpes zoster infection. The skin lesions may be followed in 1 to 2 weeks by single or multiple ocular motor palsies ipsilateral to the skin lesion, sometimes even leading to complete ophthalmoplegia (104; 116; 119). The pathophysiology may be either vasculitis or inflammatory neuritis. The efficacy of treatment with corticosteroids or acyclovir is unresolved.

Diabetes mellitus. Diabetes mellitus may very rarely cause simultaneous multiple ocular motor cranial neuropathies, sometimes together with ischemic optic neuropathy (71; 37). Spontaneous recovery within 2 to 3 months is typical.

Temporal arteritis. Temporal arteritis can also cause simultaneous cranial neuropathies, and in elderly patients with a history of headache, mild anemia, jaw and facial pain, and arthritis, it should be a consideration (158).

Blunt head trauma. Blunt head trauma may cause multiple ocular motor palsies and is the most common cause in children (68).

Brainstem lesions. Brainstem lesions are unusual causes of multiple ocular motor palsies (160; 178; El Ouail 2012; 09). The lesions damage the intraparenchymal segments of the nerves. The distinctive features are that other neurologic manifestations, including nystagmus, skew deviation, and ataxia, are usually present.

Some authors advocate botulinum toxin injection into the antagonist extraocular muscles to protect against contracture during the period of prolonged recovery from ocular motor palsy (93). If recovery is incomplete, one may continue symptomatic treatment with monocular patching or prisms or consider surgery for strabismus or ptosis once it is clear that the magnitude of the deficit has been stable for at least 1 year.

Ocular motor palsies may linger after the apparent resolution of many causes. One series reported improvement in 94% of patients with Tolosa-Hunt but in only 25% of patients with neoplasm-based cavernous sinus syndrome (12). Although 69% of patients with fungal cavernous sinus syndromes had improvement, 25% of patients died of their disease. In some patients, it may take 3 years to recover fully (49). Ptosis recovers first, followed by iris sphincter function, and finally by ocular ductions (106).

Differential diagnosis

Extraocular muscle disorders, myasthenia gravis, and brainstem lesions can present with clinical manifestations that imitate those of multiple ocular motor palsies.

Inflammation of extraocular muscles. This condition may mimic multiple ocular motor palsies. Graves ophthalmopathy can be distinguished by producing chemosis, eyelid and conjunctival congestion, lid retraction and lag, and exophthalmos. Ophthalmoparesis is based on a combination of weakness and restriction due to edema, inflammation, and fibrosis of the extraocular muscles and periorbital tissues. The forced duction test can confirm restriction. Under topical anesthesia, the eye is placed as far into the limited range as possible. Then, the examiner determines if the eye can be moved farther by using forceps, a cotton-tipped applicator, or a suction duction plunger similar to that used to remove contact lenses. If no resistance is met as the examiner pulls or pushes the eye in the direction of limited active motion, then the eye is not restricted. Orbital imaging, including ultrasound, CT scan, and MRI, can show the muscle enlargement characteristic of Graves ophthalmopathy. The pupils are not involved in Graves ophthalmopathy. The optic nerve can be compressed by enlarged extraocular muscles.

Chronic progressive external ophthalmoplegia. Chronic progressive external ophthalmoplegia is a mitochondrial myopathy that causes slowly progressive bilateral ptosis and symmetric extraocular limitation, usually without diplopia. It spares the pupils, but orbicularis involvement is common (187). It begins in childhood or adolescence and can be associated with cardiac conduction defects and pigmentary retinopathy (Kearns Sayre syndrome). Other features include short stature, hearing loss, and endocrine and bone abnormalities. Deletions in mitochondrial DNA are often present, and muscle biopsy shows ragged-red fibers (130; 147).

Brainstem syndromes. Brainstem syndromes can cause ophthalmoplegia in stroke or cancer and following medication use. In dorsal midbrain lesions (Parinaud syndrome), the defining ophthalmologic features include fixed pupils, convergence-retraction nystagmus, lid retraction (Collier’s sign), light-near dissociation, and paralysis of upward gaze. Midbrain tegmental syndromes (designated by eponyms such as Claude, Benedict, Nothnagel, and Weber) usually cause single ocular motor palsies. They can be distinguished by their additional neurologic features, such as tremor in Claude syndrome, tremor and chorea in Benedict syndrome, ataxia in Nothnagel syndrome, and hemiparesis in Weber syndrome. Lesions affecting the base of the pons that involve the corticospinal tracts cause contralateral hemiparesis and ipsilateral facial nerve palsy. These presentations are part of the Millard-Gubler and Foville syndromes (06).

Paraneoplastic brainstem encephalitis associated with anti-Hu antibodies. Paraneoplastic brainstem encephalitis associated with anti-Hu antibodies can progress over a few months from upgaze paresis with slowed horizontal saccades and gaze-paretic nystagmus to bilateral ptosis and complete external ophthalmoplegia (189). Some patients undergoing cardiovascular bypass or aortic surgery with deep hypothermia emerge with horizontal and vertical supranuclear ophthalmoplegia that spares vestibulo-ocular movements. Recovery usually occurs slowly over weeks to months (26; 182). MRI in such cases often shows diffuse white matter lesions. The origin of this syndrome is unclear but may reflect diffuse damage to cerebral centers that initiate gaze.

Medication-induced brainstem syndromes. Medication-induced brainstem syndromes have been reported after administration of phenytoin (128), phenobarbital, primidone, carbamazepine, and amitriptyline. They are likely supranuclear disorders, possibly due to increased GABA inhibition in the vestibulocerebellum.

Myasthenia gravis. Myasthenia gravis can produce any ocular motor pattern and ptosis. It is usually bilateral but asymmetric. Variability and fatigability are key signs. Repetitive nerve conduction studies (50% sensitive) and assays for antibodies to acetylcholine receptors are useful but have low sensitivities when myasthenia is confined to the levator and extraocular muscles (168; 39; 111; 138). More than 50% of patients with ocular myasthenia gravis are seronegative for myasthenia gravis markers (34). In recent years, new video-based eye tracking has demonstrated a subclinical detection of myasthenia gravis (21). The single-fiber EMG test is highly sensitive. The pupils, optic nerves, and trigeminal nerve are not involved in myasthenia.

Botulism. Botulism is another neuromuscular junction disorder that may mimic multiple ocular motor palsies. Signs of cholinergic autonomic hypofunction, such as dilated unreactive pupils, urinary retention, and decreased bowel sounds, are important clues to diagnosis.

Diagnostic workup

MRI of the orbit and sella turcica, including cavernous sinus and MR angiography, are the diagnostic procedures of choice (28; 73; 114). MRI sequences should include axial and coronal sections of the orbit and cavernous sinus with fat suppression and gadolinium. Biopsies of imaged lesions may be required. Blood cultures or nasal biopsies are indicated if infection is suspected. MR and CT angiograms have a 95% specificity and 90% sensitivity for intracavernous aneurysms measuring 3 mm or greater in diameter (102; 132).

Investigation of carotid-cavernous fistulas depends on excluding orbital causes and visualizing abnormal flow patterns in the cavernous sinus (126; 150; 62; 66). MRI reveals shunted blood in the cavernous sinus and superior ophthalmic vein as well as increased volume of the cavernous sinus (91; 02). Digital subtraction angiography remains the gold standard for classifying and diagnosing carotid-cavernous fistulae (72; 175; 62).

In septic bacterial thrombosis, blood cultures are typically positive in 70% (156; 23). Complete blood count, ESR, C-reactive protein, ACE level, P-ANCA, C-ANCA, ANA, and protein electrophoresis can help in suspected temporal arteritis, sarcoidosis, Wegener granulomatosis, Churg-Strauss syndrome, systemic lupus erythematosus, rheumatoid arthritis, multiple myeloma, and lymphoma (90; 44).

For fungal cavernous sinus or orbital vein thrombosis, biopsy of the paranasal sinus, nasopharynx, or orbit is indicated (145; 81; 82; 69). Fine-needle aspiration with CT guidance has been employed safely and effectively for lesions of the anterior cavernous sinus (134). MR and CT venography demonstrate high sensitivity and specificity in detecting cavernous sinus thrombosis (44).

The diagnosis of Tolosa-Hunt syndrome relies on MRI and CT imaging. MRI can reveal signal changes and enlargement of the cavernous sinus, accompanied by convex bowing of its lateral wall (51; 139). CT imaging may show occlusion of the superior ophthalmic vein and intra-orbital changes that could indicate either contiguous orbital inflammation or secondary effects of vascular occlusion (50). Imaging also plays a crucial role in ruling out masses because Tolosa-Hunt syndrome accounts for only 3% of cavernous sinus syndromes and is, therefore, a diagnosis made by exclusion (158; 136; 85).

References

01: Abramson E, Wilson D, Arky R. Rhinocerebral phycomycosis in association with diabetic ketoacidosis: report of two cases and a review of clinical and experimental experience with amphotericin B therapy. Ann Intern Med 1967;66:735-42. PMID 4960691
02: Adam CR, Shields CL, Gutman J, et al. Dilated superior ophthalmic vein: clinical and radiographic features of 113 cases. Ophthalmic Plast Reconstr Surg 2018;34(1):68-73. PMID 28141624
03: al-Din N, Anderson M, Eeg-Olofsson O, Trontelj T. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia, and areflexia: observations on 20 patients. Acta Neurol Scand 1994;89:87-94. PMID 8191882
04: Alam MS, Jain M, Mukherjee B, et al. Visual impairment in high flow and low flow carotid cavernous fistula. Sci Rep 2019;9(1):12872. PMID 31492949
05: Alatzides GL, Opitz M, Li Y, et al. Management of carotid cavernous fistulas: a single center experience. Front Neurol 2023;14:1123139. PMID 36846124
06: Ameri M, Al-Zubidi N, Vickers A, Kini A, Al Othman B. Ophthalmologic manifestations of brainstem stroke syndromes. American Academy of Ophthalmology. Available at: EyeWiki. Accessed December 9, 2023.
07: Aranyi Z, Szabo G, Szepesi B, Folyovich A. Proximal conduction abnormality of the facial nerve in Miller Fisher syndrome: a study using transcranial magnetic stimulation. Clin Neurophysiol 2006;117(4):821-7. PMID 16442344
08: Arthur A, Sivadasan A, Mannam P, et al. Tolosa-Hunt syndrome: long-term outcome and role of steroid-sparing agents. Ann Indian Acad Neurol 2020;23(2):201-5. PMID 32189862
09: Bailey MD, Bindiganavile SH, Lee AG. Exotropic bilateral internuclear ophthalmoplegia following a superior cerebellar artery aneurysm clipping. Can J Ophthalmol 2021;56(3):211-2. PMID 33080178
10: Barrow D, Spector R, Braun I, Landman J, Tindall S, Tindall G. Classification and treatment of spontaneous carotid-cavernous fistulas. J Neurosurg 1985;62:248-56. PMID 3968564
11: Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroopthalmol 1992;12:57-63. PMID 1532603
12: Bhatkar S, Goyal MK, Takkar A, et al. Cavernous sinus syndrome: a prospective study of 73 cases at a tertiary care centre in Northern India. Clin Neurol Neurosurg 2017;155: 63-9. PMID 28260625
13: Borgohain R, Radhakrishna H, Singh A, Mohandas S, Reddy J. Bilateral cavernous sinus thrombosis causing Korsakoff’s syndrome. J Neurol Neurosurg Psychiatry 1995;58:514-6. PMID 7738577
14: Brandy-Garcia A, Suarez-Cuervo C, Caminal-Montero L. Tolosa-Hunt syndrome as an initial presentation of sarcoidosis. Reumatol Clin (Engl Ed) 2021;17(3):178-9. PMID 31488356
15: Briggs RG, Bonney PA, Algan O, Patel AD, Sughrue ME. Bilateral Carotid-cavernous fistulas treated with partial embolization and radiosurgery. Cureus 2019;11(10):e5886. PMID 31772856
16: Brown BL, Lopes D, Miller DA, et al. The fate of cranial neuropathy after flow diversion for carotid aneurysms. J Neurosurg 2015:1-7. PMID 26473786
17: Carey RAB, Nathaniel SD, Das S, Sudhakar S. Cavernous sinus syndrome due to skull base metastasis: a rare presentation of hepatocellular carcinoma. Neurol India 2015;63(3):437-9. PMID 26053823
18: Castello MM, Montatixe DE, Español CC, et al. Incomplete cavernous sinus syndrome as the initial manifestation of a previously undetected metastatic prostate adenocarcinoma. Head Neck 2017;39(7):E77-80. PMID 28474478
19: Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome. Neurology 1993;43:1911-7. PMID 8413947
20: Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-9. PMID 1514781
21: Chisari CG, Sciacca G, Reggio E, Terravecchia C, Patti F, Zappia M. Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis. Neurol Sci 2023;44(7):2555-9. PMID 36971995
22: Chuang TY, Burda K, Teklemariam E, Athar K. Tolosa-Hunt syndrome presenting after COVID-19 vaccination. Cureus 2021;13(7):e16791. PMID 34513398
23: Clifford-Jones R, Ellis C, Stevens J, Turner A. Cavernous sinus thrombosis. J Neurol Neurosurg Psychiatry 1982;45:1092-7. PMID 7161604
24: Cogan DG. Neurology of the ocular muscles. 2nd ed. Illinois: Charles C Thomas, 1956.
25: Coppeto J, Hoffman H. Tolosa-Hunt syndrome with proptosis mimicked by giant aneurysm of posterior cerebral artery. Arch Neurol 1981;38:54-5. PMID 7458726
26: Crino P, Galetta S, Sater R, et al. Clinicopathologic study of paraneoplastic brainstem encephalitis and ophthalmoparesis. J Clin Neuroopthalmol 1996;16:44-8. PMID 8963420
27: Dacus MR, Nickele C, Welch BG, et al. Matricidal cavernous aneurysms: a multicenter case series. J Neurointerv Surg 2019;11(6):584-90. PMID 30814330
28: Daniels D, Pech P, Mark L, Pojunas K, Williams A, Haughton V. Magnetic resonance imaging of the cavernous sinus. AJNR 1985;6:187-92. PMID 3872556
29: Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 2020;95(5):221-3. PMID 32358218
30: DiNubile M. Septic thrombosis of the cavernous sinus. Arch Neurol 1988;45:567-72. PMID 3282499
31: Doblan A, Kaplama ME, Ak S, et al. Cranial nerve involvement in COVID-19. Am J Otolaryngol 2021;42(5):102999. PMID 33838359
32: Dornan T, Espir M, Gale E, Tattersall R, Worthington B. Remittent painful ophthalmoplegia: the Tolosa Hunt syndrome. J Neurol Neurosurg Psychiatry 1979;42:270-5. PMID 438837
33: Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 2021;20(4):102792. PMID 33610751
34: Doughty CT, Guidon AC. Diagnostic testing for ocular myasthenia gravis: stronger together. Neurology 2020;95(13):563-4. PMID 32788244
35: Drenthen J, Maathuis EM, Visser GH, van Doorn PA, Blok JH, Jacobs BC. Limb motor nerve dysfunction in Miller Fisher syndrome. J Peripher Nerv Syst 2013;18(1):25-9. PMID 23521640
36: El-Kholy NA, El-Fattah AMA, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity. Laryngoscope 2021;131(12):2652-8. PMID 34009676
37: Eshbaugh C, Siatkowski R, Smith J, Kline L. Simultaneous, multiple cranial neuropathies in diabetes mellitus. J Neuroopthalmol 1995;15:219-24. PMID 8748558
38: Estrem S, Tully R, Davis W. Rhinocerebral mucormycosis: computed tomographic imaging of cavernous sinus thrombosis. Ann Otol Rhinol Laryngol 1990;99:160-1. PMID 2301872
39: Evoli A, Tonali P, Bartoccioni E, Lo Monaco M. Ocular myasthenia: diagnosis and therapeutic problems. Acta Neurol Scand 1988;77:31-5. PMID 3354309
40: Fernandez S, Godino O, Martínez-Yelamos S, et al. Cavernous sinus syndrome: a series of 126 patients. Medicine (Baltimore) 2007;86(5):278-81. PMID 17873757
41: Fowler T, Earl C, McAllister V, McDonald W. Tolosa Hunt syndrome. The dangers of an eponym. Brit J Ophthalmol 1975;59:149-54. PMID 1131355
42: Fukami Y, Wong AH, Funakoshi K, Safri AY, Shahrizaila N, Yuki N. Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum. Eur J Neurol 2016 Feb;23(2):320-6. PMID 26176883
43: Gatto LAM, Tacla R, Koppe GL, Junior ZD. Carotid cavernous fistula after percutaneous balloon compression for trigeminal neuralgia: endovascular treatment with coils. Surg Neurol Int 2017;8:36. PMID 28458950
44: Geng B, Wu X, Malhotra A. Septic cavernous sinus thrombosis-case series and review of the literature. Clin Neurol Neurosurg 2020;197:106092. PMID 32693341
45: Goadsby P, Lance J. Clinicopathological correlation in a case of painful ophthalmoplegia: Tolosa Hunt syndrome. J Neurol Neurosurg Psychiatry 1989;52:1290-3. PMID 2592972
46: Goldenberg-Cohen N, Curry C, Miller NR, Tamargo RJ, Murphy KPJ. Long term visual and neurological prognosis in patients with treated and untreated cavernous sinus aneurysms. J Neurol Neurosurg Psychiatry 2004;75(6):863-7. PMID 15146001
47: Goldberg R, Goldey S, Duckwiler G, Vinuela F. Management of cavernous sinus-dural fistulas. Indications and techniques for primary embolization via the superior ophthalmic vein. Arch Ophthalmol 1996;114:707-14. PMID 8639083
48: Goldberg-Stern H, Melamed E, Gadoth N. Abnormal evoked potentials in Miller-Fisher syndrome: further evidence of combined peripheral and central demyelination. J Neurol Neurosurg Psychiatry 1994;57:506. PMID 8164009
49: Golnik KC, Miller NR. Late recovery of function after oculomotor nerve palsy. Am J Ophthalmol 1991;111:566-70. PMID 2021163
50: Goto Y, Goto I, Hosokawa S. Neurological and radiological studies in painful ophthalmoplegia: Tolosa-Hunt syndrome and orbital pseudotumour. J Neurol 1989;236(8):448-51. PMID 2614488
51: Goto Y, Hosokawa S, Goto I, Hirakata R, Hasuo K. Abnormality in the cavernous sinus in three patients with Tolosa Hunt syndrome: MRI and CT findings. J Neurol Neurosurg Psychiatry 1990;53:231-4. PMID 2324755
52: Goyal P, Mangla R, Gupta S, et al. Pediatric congenital cerebrovascular anomalies. J Neuroimaging 2019;29(2):165-81. PMID 30378722
53: Gupta S, Thakur AS, Bhardwaj N, Singh H. Carotid cavernous sinus fistula presenting with pulsating exophthalmos and secondary glaucoma. J Indian Med Assoc 2008;106(5):312, 346. PMID 18839638
54: Halbach V, Hieshima G, Higashida R, Reicher M. Carotid cavernous fistulae: indications for urgent treatment. AJNR 1987;8:627-33. PMID 3497549
55: Halbach V, Higashida R, Dowd C, Barnwell S, Hieshima G. Treatment of carotid-cavernous fistulas associated with Ehlers-Danlos syndrome. Neurosurg 1990;26:1021-7. PMID 2362658
56: Hamer J. Incidence and prognosis of oculomotor palsy after subarachnoid hemorrhage due to ruptured aneurysm of posterior communicating artery. In: Samii M, Jannetta PJ, editors. The cranial nerves. Berlin: Springer-Verlag, 1981:237-40.
57: Hamer J. Prognosis of oculomotor palsy in patients with aneurysms of the posterior communicating artery. Acta Neurochir 1982;66:173-85. PMID 7168392
58: Hao R, He Y, Zhang H, Zhang W, Li X, Ke Y. The evaluation of the ICHD-3 beta diagnostic criteria for Tolosa-Hunt syndrome: a study of 22 cases of Tolosa-Hunt syndrome. Neurol Sci 2015;36(6):899-905. PMID 25736249
59: Harley R. Paralytic strabismus in children. Etiologic incidence and management of the third, fourth and sixth nerve palsies. Ophthalmol 1980;87:24-43. PMID 7375084
60: Harrison AR, Wirtschafter JD. Ocular neuromyotonia in a patient with cavernous sinus thrombosis secondary to mucormycosis. Am J Ophthalmol 1997;124(1):122-3. PMID 9222252
61: Hedges TR, Leung LS. Parasellar and orbital apex syndrome caused by aspergillosis. Neurology 1976;26:117-20. PMID 943065
62: Henderson AD, Miller NR. Carotid-cavernous fistula: current concepts in aetiology, investigation, and management. Eye (Lond) 2018;32(2):164-72. PMID 29099499
63: Hida C, Yamamoto T, Endo K, Tanno Y, Saito T, Tsukamoto T. Inflammatory involvement of the hypophysis in Tolosa-Hunt syndrome. Intern Med 1995;34:1093-6. PMID 8774971
64: Hidaka H, Terashima H, Tsukamoto Y, Nakata H, Matsuoka S. Radiotherapy of dural arteriovenous malformations in the cavernous sinus. Radiation Med 1989;7:160-4. PMID 2587806
65: Hirai T, Korogi Y, Goto K, Ogata N, Sakamoto Y, Takahashi M. Carotid-cavernous fistula and aneurysmal rupture associated with fibromuscular dysplasia. Acta Radiol 1996;37:49-51. PMID 8611324
66: Hisaeda E, Shimada H, Ogata T, Fukuda K, Higashi T, Inoue T. Detection and differentiation of dural arteriovenous fistulas in the transverse sinus/sigmoid sinus and cavernous sinus using carotid ultrasound: importance of evaluation of the occipital artery. J Ultrasound Med 2021;40(4):683-7. PMID 32833229
67: Holland LJ, Ranzcr KM, Harrison JD, Brauchli D, Wong Y, Sullivan TJ. Endovascular treatment of carotid-cavernous sinus fistulas: ophthalmic and visual outcomes. Orbit 2019;38(4):290-9. PMID 30465621
68: Holmes JM, Mutyala S, Maus TL, Grill R, Hodge DO, Gray DT. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol 1999;127(4):388-92. PMID 10218690
69: Horowitz A, Spendel D, Kraut R, Orentlicher G. Cavernous sinus thrombosis as a result of a fungal infection: a case report. J Oral Maxillofac Surg 2013;71(11):1899.e1-e5. PMID 23945514
70: Iida K, Uozumi T, Arita K, Nakahara T, Ohba S, Satoh H. Steal phenomenon in a traumatic carotid-cavernous fistula. J Trauma 1995;39:1015-7. PMID 7473990
71: Jabs D, Miller N, Green W. Ischaemic optic neuropathy with painful ophthalmoplegia in diabetes mellitus. Brit J Ophthalmol 1981;65:673-8. PMID 7317318
72: Jacobs SM, Arias EJ, Derdeyn CP, Couch SM, Custer PL. Carotid cavernous sinus fistulas without superior ophthalmic vein enlargement. Ophthal Plast Resconstr Surg 2015;31(3):191-6. PMID 25105521
73: Jain R, Sawhney S, Koul RL, Chand P. Tolosa Hunt syndrome: MRI appearances. J Med Imaging Radiat Oncol 2008;52(5):447-51. PMID 19032389
74: Jamal G, Ballantyne J. The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller-Fisher syndrome). Brain 1988;111:95-114. PMID 2835120
75: Jang Y, Choi JH, Chae JH, Lim BC, Kim SJ, Jung JH. Pediatric Miller Fisher syndrome: characteristic presentation and comparison with adult Miller Fisher syndrome. J Clin Med 2020;9(12):3930. PMID 33287444
76: Kashiwagi S, Tsuchida E, Goto K, et al. Balloon occlusion of a spontaneous carotid-cavernous fistula in Ehlers-Danlos syndrome type IV. Surg Neurol 1993;39:187-90. PMID 8456380
77: Kassis SZ, Jouanneau E, Tahon FB, Salkine F, Perrin G, Turjman F. Recovery of third nerve palsy after endovascular treatment of posterior communicating artery aneurysms. World Neurosurg 2010;73(1):11-6. PMID 20452864
78: Keane JR. Acute bilateral ophthalmoplegia: 60 cases. Neurology 1986;36:279-81. PMID 3945401
79: Keane JR. Multiple cranial nerve palsies: analysis of 979 cases. Arch Neurol 2005;62(11):1714-7. PMID 16286545
80: Keltner J, Satterfield D, Dublin A, Lee B. Dural and carotid cavernous sinus fistulas. Diagnosis, management and complications. Ophthalmol 1987;94:1585-600. PMID 3323984
81: Kennerdell JS, Dekker A, Johnson BL. Orbital fine needle biopsy: the result of its use in 50 patients. Neuroophthalmology 1980a;1:117-21.
82: Kennerdell JS, Dubois PJ, Dekker A, et al. CT-guided fine needle aspiration biopsy of orbital optic nerve tumors. Ophthalmology 1980b;87:491-6. PMID 7413137
83: Khan MA, Hashmi SM, Prinsley PR, Premachandra DJ. Reidel's thyroiditis and Tolosa-Hunt syndrome, a rare association. J Laryngol Otol 2004;118(2):159-61. PMID 14979959
84: Khurana M, Alam MS, Balekudaru S, et al. Intraocular pressure in the eyes of patients with carotid-cavernous fistulas: profile, intereye asymmetry, and treatment outcomes. J Glaucoma 2019;28(12):1074-8. PMID 31658226
85: Kim H, Oh SY. The clinical features and outcomes of Tolosa-Hunt syndrome. BMC Ophthalmol 2021;21(1):237. PMID 34044807
86: Kim SR, Kanda F, Kobessho H, et al. Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves. World J Gastroenterol 2006;12(41):6727-9. PMID 17075993
87: Kim JM, Kang KW, Kim H, Lee SH, Kim TS, Park MS. Septic cavernous sinus thrombosis after minor head trauma: a case report. Medicine (Baltimore) 2022;101(10):e29057. PMID 35451418
88: Kita D, Tachibana O, Nagai Y, Sano H, Yamashita J. Granulomatous pachymeningitis around the sella turcica (Tolosa-Hunt syndrome) involving the hypophysis--case report. Neurol Med Chir (Tokyo) 2007;47(2):85-8. PMID 17317948
89: Kline L. Tolosa Hunt syndrome. Surv Ophthalmol 1982;27:79-95. PMID 6755785
90: Knopf HL. An unusual case of painful ophthalmoplegia in a patient with rheumatoid arthritis. Ann Ophthalmol 1989;21:412-3. PMID 2619150
91: Komiyama M, Fu Y, Yagura H, Yasui T, Hakuba A, Nishimura S. MR imaging of dural AV fistulas at the cavernous sinus. J Comp Assist Tomogr 1990a;14:397-401. PMID 2335608
92: Konishi Y, Hieshima G, Hara M, Yoshino K, Yano K, Takeuchi K. Congenital fistula of the dural carotid-cavernous sinus: case report and review of the literature. Neurosurg 1990;27:120-6. PMID 2198482
93: Kubatko-Zielinska A, Krzystkowa KM, Madroszkiewicz A, Wojcik E, Filipowicz E. Principles and results of treatment in acquired paralysis. Klin Oczna 1995;97:147-51. PMID 7650888
94: Kuether T, O'Neill O, Nesbit G, Barnwell S. Direct carotid cavernous fistula after trigeminal balloon microcompression gangliolysis: case report. Neurosurg 1996;39:853-5. PMID 8880781
95: Kursun E, Turunc T, Demiroglu YZ, Aliskan HE, Arslan AH. Evaluation of 28 cases of mucormycosis. Mycoses 2015;58(2):82-7. PMID 25590855
96: Kushner F. Carotid-cavernous fistula as a complication of carotid endarterectomy. Ann Ophthalmol 1981;13:979-82. PMID 7294640
97: Kwon HS, Kim TY, Kim JH, et al. Use of methotrexate in the management of recurrent Tolosa-Hunt syndrome: two case reports. Medicine (Baltimore) 2020;99(17):e19882. PMID 32332660
98: Lakke JP. Superior orbital fissure syndrome. Report of a case caused by local pachymeningitis. Arch Neurol 1962;7:289-300. PMID 13928165
99: Lehrer R. Mucormycosis. Ann Int Med 1980;93:93-108. PMID 6772062
100: Levine S, Twyman R, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988;38:517-22. PMID 3281056
101: Lewis AI, Tomsick TA, Tew JM Jr, Lawless MA. Long-term results in direct carotid cavernous fistulas after treatment with detachable balloons. J Neurosurg 1996;84:400-4. PMID 8609550
102: Linskey M, Sekhar L, Hirsch W, Yonas H, Horton J. Aneurysms of the intracavernous carotid artery: clinical presentation, radiographic features and pathogenesis. Neurosurgery 1990a;26:71-9. PMID 2294481
103: Linskey M, Sekhar L, Hirsch W, Yonas H, Horton J. Aneurysms of the intracavernous carotid artery: natural history and indications for treatment. Neurosurgery 1990b;26:71-9. PMID 2362671
104: Marsh R, Dulley B, Kelly V. External ocular motor palsies in ophthalmic zoster: a review. Brit J Ophthalmol 1977;61:677-82. PMID 338027
105: Masson-Roy J, Savard M, Mackey A. Carotid cavernous fistula in a patient with type IV Ehlers-Danlos syndrome. Can J Neurol Sci 2017;44(4):427-8. PMID 28228175
106: Mavilio N, Pisani R, Rivano C, Testa V, Spaziante R, Rosa M. Recovery of third nerve palsy after endovascular packing of internal carotid-posterior communicating artery aneurysms. Interv Neuroradiol 2000;6(3):203-9. PMID 20667199
107: Meadows S. Intracavernous aneurysms of the internal carotid artery. Arch Ophthalmol 1959;62:566-74.
108: Micieli JA, Newman NJ, Barrow DL, Biousse V. Intracranial aneurysms of neuro-ophthalmologic relevance. J Neuroophthalmol 2017;37(4):421-39. PMID 28665866
109: Miller N, Monsein L, Debrun G, Tamargo R, Nauta H. Treatment of carotid-cavernous sinus fistulas using a superior ophthalmic vein approach. J Neurosurg 1995;83:838-42. PMID 7472552
110: Montecucco C, Caporali R, Pacchetti C, Turla M. Is Tolosa Hunt syndrome a limited form of Wegener’s granulomatosis. Report of two cases with anti-neutrophil cytoplasmic antibodies. Brit J Rheumatol 1993;32:640-1. PMID 8339143
111: Morel E, Vernet-der-Garabedian B, Eymard B, Raimond F, Bustarret F, Bach J. Binding and blocking antibodies to the human acetylcholine receptor: are they selected in various myasthenia gravis forms. Immunol Res 1988;7:212-7. PMID 3193008
112: Mulvey CL, Kiell EP, Rizzi MD, Buzi A. The microbiology of complicated acute sinusitis among pediatric patients: a case series. Otolaryngol Head Neck Surg 2019;160(4):712-9. PMID 30481479
113: Munawar K, Nayak G, Fatterpekar GM, et al. Cavernous sinus lesions. Clin Imaging 2020;68:71-89. PMID 32574933
114: Nadarajah J, Madhusudan KS, Yadav AK, Chandrashekhara SH, Kumar A, Gupta AK. MR imaging of cavernous sinus lesions: pictorial review. J Neuroradiol 2015;42(6):305-19. PMID 26421483
115: Nassrallah G, Sun V, Guiot MC, Mikhail M, Arthurs B. Cavernous sinus syndrome associated with metastatic colorectal cancer and perineural spread along the trigeminal nerve. Am J Ophthalmol Case Rep 2017;6:67-70. PMID 29260062
116: Nishioka K, Fujishima K, Kobayashi H, Mizuno Y, Okuma Y. An extremely unusual presentation of varicella zoster viral infection of cranial nerves mimicking Garcin syndrome. Clin Neurol Neurosurg 2006;108(8):772-4. PMID 16226370
117: Onec B, Oksuzoglu B, Hatipoglu HG, Onec K, Azak A, Zengin N. Cavernous sinus syndrome caused by metastatic colon carcinoma. Clin Colorectal Cancer 2007;6(8):593-6. PMID 17681107
118: Ono K, Oishi H, Tanoue S, et al. Direct carotid-cavernous fistulas occurring during neurointerventional procedures. Interv Neuroradiol 2016;22(1):91-6. PMID 26628454
119: Osman SA. Successful oral treatment of third cranial nerve palsy and optic neuritis from neglected herpes zoster in an immunocompetent patient. Am J Ophthalmol Case Rep 2020;20:100953. PMID 33294726
120: Park SH, Park KS, Kang DH, Hwang JH, Hwang SK. Stereotactic radiosurgery for dural carotid cavernous sinus fistulas. World Neurosurg 2017;106:836-43. PMID 28465265
121: Partridge BM, Chin AT. Cerebral aspergilloma. Post Grad Med J 1981;57(669):439-42. PMID 6796951
122: Pashapour A, Mohammadian R, Salehpour F, et al. Long-term endovascular treatment outcome of 46 patients with cavernous sinus dural arteriovenous fistulas presenting with ophthalmic symptoms. A non-controlled trial with clinical and angiographic follow-up. Neuroradiol J 2014;27(4):461-70. PMID 25196621
123: Patil C, Kumar A, Battula V, et al. Radiological manifestations of rhino-orbito-cranial mucormycosis in COVID-19 patients correlated with pathological and clinical outcomes and emphasis on magnetic resonance imaging-based scoring system. Cureus 2023;15(3):e35745. PMID 37020477
124: Petty R, Wardlaw J, Kennedy P, et al. Panhypopituitarism after cavernous sinus thrombosis. J Neurol Neurosurg Psychiatry 1994;7:1010-1. PMID 8057098
125: Phan K, Xu J, Leung V, et al. Orbital approaches for treatment of carotid cavernous fistulas: a systematic review. World Neurosurg 2016;96:243-51. PMID 27586179
126: Phelps C, Thompson H, Ossoinig K. The diagnosis and prognosis of atypical carotid cavernous fistula (red-eyed shunt syndrome). Am J Ophthalmol 1982;93:423-36. PMID 7072809
127: Pimentel MC, Pappaterra S, Batlle JF. Association of carotid-cavernous fistula with central retinal vein occlusion. Ophthalmology 2017;124(4):576. PMID 28335941
128: Puri V, Chaudhry N. Total external ophthalmoplegia induced by phenytoin: a case report and review of literature. Neurol India 2004;52(3):386-7. PMID 15472437
129: Richards B, Jones F, Younge B. Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves. Am J Ophthalmol 1992;113:489-96. PMID 1575221
130: Ringel SP, Wilson WB, Barden MT. Extraocular muscle biopsy in chronic progressive external ophthalmoplegia. Ann Neurol 1979;6:326-39. PMID 554523
131: Rodrigues T, Willinsky R, Agid R, TerBrugge K, Krings T. Management of dural carotid cavernous fistulas: a single-centre experience. Eur Radiol 2014;24(12):3051-8. PMID 25038862
132: Rodriguez-Regent C, Edjlali-Goujon M, Trystram D, et al. Non-invasive diagnosis of intracranial aneurysms. Diagn Interv Imaging 2014;95(12):1163-74. PMID 25465118
133: Rowe F, VIS group UK. Prevalence of ocular motor cranial nerve palsy and associations following stroke. Eye (Lond) 2011;25(7):881-7. PMID 21475314
134: Rowed DW, Kassei EE, Lewis AJ. Transorbital intracavernous needle biopsy in painful ophthalmoplegia. J Neurosurgery 1985;62:776-80. PMID 3989599
135: Rucker CW. The causes of paralysis of the third, fourth, and sixth cranial nerves. Am J Ophthalmol 1966;61:1293-8. PMID 5938012
136: Rush J, Younge B. Paralysis of cranial nerves III, IV and VI: cause and prognosis in 1000 cases. Arch Ophthalmol 1981;99:76-9. PMID 7458744
137: Sadun F, Feldon S, Weiss M, Krieger M. Septic cavernous sinus thrombosis following transsphenoidal craniotomy. J Neurosurg 1996;85:949-52. PMID 8893738
138: Salih MA, Salih MA, Mustafa AA, et al. Ocular neostigmine drops for diagnosing myasthenia gravis. J Neurol Neurophysiol 2013;S11:004.
139: Sanchez Vallejo R, Lopez-Rueda A, Olarte AM, San Roman L. MRI findings in Tolosa-Hunt syndrome (THS). BMJ Case Rep 2014;2014:bcr2014206629. PMID 25368129
140: Sanchez van Kammen M, Male C, Connor P, Monagle P, Coutinho JM, Lensing AW; EINSTEIN-Jr CVT investigators. Anticoagulant treatment for pediatric infection-related cerebral venous thrombosis. Pediatr Neurol 2022;128:20-4. PMID 35032886
141: Sanjay S, Chan EW, Gopal L, Hegde SR, Chang BC. Complete unilateral ophthalmoplegia in herpes zoster ophthalmicus. J Neuroophthalmol 2009;29(4):325-37. PMID 19952908
142: Sasi S, Nair AP, Kolleri J, Alzibdeh A, Maslamani MS. Disseminated tuberculosis masquerading as Tolosa-Hunt syndrome in initial presentation: a case report with literature review. Radiol Case Rep 2023;18(3):1353-7. PMID 36712191
143: Schievink W, Piepgras D, Earnest F 4th, Gordon H. Spontaneous carotid-cavernous fistulae in Ehler-Danlos syndrome (type IV). J Neurosurg 1991;74:991-8. PMID 2033461
144: Seixas NB, Belsuzarri TAB, Belsuzarri NCB, Pozetti M, Araujo JFM. Cavernous sinus syndrome as the first manifestation of metastatic breast disease. Surg Neurol Int 2017;8:40. PMID 28480103
145: Sekhar L, Dujovny M, Rao G. Carotid cavernous sinus thrombosis caused by Aspergillus fumigatus. J Neurosurg 1980;52:120-5. PMID 6985651
146: Shiode T, Oya S, Matsui T. A case of the internal carotid artery-posterior communicating artery aneurysm mimicking Tolosa-Hunt syndrome. NMC Case Rep J 2014;2(1):1-3. PMID 28663952
147: Shiraishi W, Tateishi T, Hashimoto Y, Yamasaki R, Kira JI, Isobe N. [Chronic progressive external ophthalmoplegia that could not be diagnosed by biceps muscle biopsy, but was genetically diagnosed by extraocular muscle biopsy]. Rinsho Shinkeigaku 2022;62(12):946-51. PMID 36450492
148: Smith JL, Taxdal DS. Painful ophthalmoplegia. The Tolosa-Hunt syndrome. Am J Ophthalmol 1966;61(6):1466-72. PMID 5938314
149: Southwick FS, Richardson EP Jr, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) 1986;65:82-106. PMID 3512953
150: Spector R. Echographic diagnosis of dural carotid-cavernous sinus fistulas. Am J Ophthalmol 1991;111:77-83. PMID 1985495
151: Stiebel-Kalish H, Kalish Y, Bar-On RH, et al. Presentation, natural history, and management of carotid cavernous aneurysms. Neurosurgery 2005;57(5):850-7. PMID 16284555
152: Suzuki J, Mizoi K, Sato T. Disturbances of ocular movement due to cerebral aneurysm: Based upon the experience in 1000 directly operated patients. In: Samii M, Jannetta PJ, editors. The cranial nerves. Berlin, Springer-Verlag, 1981:229-36.
153: Suzuki T, Chiba A, Kusunoki S, Chikuda M, Fujita T, Misu K. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. Br J Ophthalmol 1998;82(8):916-8. PMID 9828777
154: Takakura Y, Yamaguchi Y, Miyoshi T. Neurosyphilis presenting the left total ophthalmoplegia: a case report. Rinsho Shinkeigaku 2004;44(4-5):296-8. PMID 15287513
155: Tanaka T, Hayakawa M, Sadato A, et al. Transvenous embolization for carotid-cavernous fistula in a patient with vascular type of Ehlers-Danlos syndrome--direct superior ophthalmic vein approach: case report. Neurol Med Chir (Tokyo) 2014;54(2):155-60. PMID 24418783
156: Taylor P. Cavernous sinus thrombophlebitis. Brit J Ophthalmol 1957;41:228-37. PMID 13413138
157: Taylor J, Vuu S, Ang D. Mucormycosis necrotizing soft tissue infection: a case report of fungal infection following a high-speed motorcycle accident. Cureus 2023;15(3):e35896. PMID 37033576
158: Thomas J, Yoss R. The parasellar syndrome: problems in determining etiology. Mayo Clin Proc 1970;45:617-23. PMID 5459993
159: Thurtell MJ, Chiu AL, Goold LA, et al. Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clin Experiment Ophthalmol 2012;41(6):567-76. PMID 23279383
160: Tomecek FJ, Morgan JK. Ophthalmoplegia with bilateral ptosis secondary to midbrain hemorrhage. Surg Neurol 1994;41:131-6. PMID 8115950
161: Trobe JD, Glaser JS, Post JD. Meningiomas and aneurysms of the cavernous sinus. Neuro-ophthalmologic features. Arch Ophthalmol 1978;96:457-67. PMID 629685
162: Tsirigotaki M, Ntoulios G, Lioumpas M, Voutoufianakis S, Vorgia P. Tolosa-Hunt syndrome: clinical manifestations in children. Pediatr Neurol 2019;99:60-3. PMID 30982655
163: Turunc T, Demiroglu YZ, Aliskan H, Colakoglu S, Arslan H. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res Clin Pract 2008;82(2):203-8. PMID 18760493
164: Tveteras K, Kristensen S, Dommerby H. Septic cavernous and lateral sinus thrombosis: modern diagnostic and therapeutic principles. J Laryngol Otol 1988;102:877-82. PMID 3058845
165: Vailati A, Marena C, Comis S, et al. Hashimoto’s thyroiditis in association with Tolosa Hunt syndrome: a case report. Thyroid 1993;3:125-7. PMID 8369651
166: van der Poel NA, Mourits MP, de Win MML, Coutinho JM, Dikkers FG. Prognosis of septic cavernous sinus thrombosis remarkably improved: a case series of 12 patients and literature review. Eur Arch Otorhinolaryngol 2018;275(9):2387-95. PMID 29998385
167: Vasanthapuram VH, Badakere A. Internuclear ophthalmoplegia as a presenting feature in a COVID-19-positive patient. BMJ Case Rep 2021;14(4):e241873. PMID 33849880
168: Vincent A, Newsom-Davis J. Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 1980;43:590-600. PMID 7400823
169: Vinuela F, Fox A, Debrun GM, Peerless SJ, Drake CG. Spontaneous carotid-cavernous fistulas: clinical radiological and therapeutic considerations. J Neurosurg 1984;60:976-84. PMID 6716167
170: Wang W, Li MH, Li YD, Gu BX, Lu HT. Reconstruction of the internal carotid artery after treatment of complex traumatic direct carotid-cavernous fistulas with the Willis covered stent: a retrospective study With long-term follow-up. Neurosurgery 2016;79(6):794-805. PMID 27258766
171: Weerasinghe D, Lueck CJ. Septic cavernous sinus thrombosis: case report and review of the literature. Neuroophthalmology 2016;40(6):263-76. PMID 27928417
172: Wiener J, Cron RQ. Successful treatment of pediatric Tolosa-Hunt syndrome with adalimumab. Eur J Rheumatol 2019;7(Suppl 1):1-3. PMID 31804175
173: Williams ZR. Carotid-cavernous fistulae: a review of clinical presentation, therapeutic options, and visual prognosis. Int Ophthalmol Clin 2018;58(2):271-94. PMID 29517654
174: Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993;56:204-6. PMID 8437011
175: Winegar BA, Gutierrez JE. Imaging of orbital trauma and emergent non-traumatic conditions. Neuroimaging Clin N Am 2015;25:439-56. PMID 26208419
176: Wong AH, Umapathi T, Nishimoto Y, Wang YZ, Chan YC, Yuki N. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst 2015;20(1):47-51. PMID 25640907
177: Woolen S, Gemmete JJ, Pandey AS, Chaudhary N. Dural carotid-cavernous fistula presenting with confusion and expressive aphasia. J Clin Neurosci 2015;22(11):1844-6. PMID 26113002
178: Worthington J, Halmagyi G. Bilateral total ophthalmoplegia due to midbrain hematoma. Neurology 1996;46:1176-7. PMID 8780123
179: Yamakita N, Hanamoto T, Muraoka N, et al. Hypopituitarism and diabetes insipidus with localized hypertrophic pachymeningitis (Tolosa-Hunt syndrome) associated with Hashimoto thyroiditis. Am J Med Sci 2004;327(1):38-43. PMID 14722395
180: Yanovitch T, Buckley E. Diagnosis and management of third nerve palsy. Curr Opin Ophthalmol 2007;18(5):373-8. PMID 17700229
181: Yarrington CJ. Cavernous sinus thrombosis revisited. Proc Roy Soc Med 1977;70:456-9. PMID 331338
182: Yee RD, Purvin VA. Acquired ocular motor apraxia after aortic surgery. Trans Am Ophthalmol Soc 2007;105:152-8. PMID 18427605
183: Yeh S, Foroozan R. Orbital apex syndrome. Curr Opin Ophthalmol 2004;15(6):490-8. PMID 15523194
184: Yip PK. Bilateral ptosis, ataxia and areflexia - a variant of Fisher’s syndrome. J Neurol Neurosurg Psychiatry 1991;54:1121. PMID 1783934
185: Yu AW, Finkelsztein EJ, Cheng NT. A case of Tolosa-Hunt syndrome with discoid lupus erythematosus. Neurohospitalist 2020;10(1):48-50. PMID 31839865
186: Yuan M, Tandon A, Li A, et al. Orbital apex syndrome secondary to invasive aspergillus infection: a case series and literature review. J Neuroophthalmol 2021;41(4):e631-8. PMID 33110002
187: Yu-Wai-Man P. Chronic Progressive External Ophthalmoplegia Secondary to Nuclear-Encoded Mitochondrial Genes. In: Mitochondrial Case Studies. Elsevier, 2016:159-69.
188: Yvon C, Nee D, Chan D, Malhotra R. Ophthalmoplegia associated with anti-GQ1b antibodies: case report and review. Orbit 2023;42(2):192-5. PMID: 34493154
189: Zackon DH, Sharpe JA. Midbrain paresis of horizontal gaze. Ann Neurol 1984;16:495-504. PMID 6388487
190: Zelenak M, Doval M, Gorscak JJ, Cuscela DO. Acute cavernous sinus syndrome from metastasis of lung cancer to sphenoid bone. Case Rep Oncol 2012;5(1):35-42. PMID 22379475
191: Zhang Y, Zheng H, Zhou M, He L. Teaching neuroimages: carotid-cavernous fistula caused by fibromuscular dysplasia. Neurology 2014b;82(15):e134-5. PMID 24733864
192: Zuurbier SM, Coutinho JM, Stam J, et al. Clinical outcome of anticoagulant treatment in head or neck infection-associated cerebral venous thrombosis. Stroke 2016;47(5):1271-7. PMID 27032446

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Authors

Ricky Paramo BS

Mr. Paramo of University of Connecticut has no relevant financial relationships to disclose.
See Profile
Lakshmi Leishangthem MD

Dr. Leishangthem of the University of Connecticut has no relevant financial relationships to disclose.
See Profile

Editor

Jonathan D Trobe MD

Dr. Trobe of the University of Michigan has no relevant financial relationships to disclose.
See Profile

Former Authors

Mohammad Fouladvand MD
Jason J S Barton MD PhD FRCPC
Susiani Intan MD
Heather E Moss MD PhD
Simon D Archambault

Patient Profile

Age range of presentation: 0 month to 65+ years
Sex preponderance: female>male, >2:1
Heredity: none
Population groups selectively affected: any
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Fourth [trochlear] nerve palsy: H49.1

Sixth [abducent] nerve palsy: H49.2

Cranial nerve disorder, unspecified: G52.9

Disorder of central nervous system, unspecified: G96.9

Disorders of multiple cranial nerves: G52.7
ICD-11: Fourth nerve palsy: 9C81.1

Sixth nerve palsy: 9C81.2

Disorders of cranial nerves, unspecified: 8B8Z

Disorders of multiple cranial nerves: 8B85

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Combined third, fourth, and sixth nerve palsies

Associated Disorders

Multiple ocular motor palsies

Differential Diagnosis

inflammation of extraocular muscles
chronic progressive external ophthalmoplegia
brainstem syndromes
paraneoplastic brainstem encephalitis associated with anti-Hu antibodies
medication-induced brainstem syndromes
- myasthenia gravis
- botulism

Also Relevant

Cerebellar astrocytoma
Diplopia
Ependymoma
Hereditary neuropathy with predisposition to pressure palsy
Isolated fourth nerve palsy
- Isolated sixth nerve palsy
- Multiple cranial neuropathies
- Neurosyphilis
- Third nerve palsy

Combined third, fourth, and sixth nerve palsies …

Combined third, fourth, and sixth nerve palsies

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and management

Differential diagnosis

Diagnostic workup

Media

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Giant cell arteritis

Ischemic optic neuropathy

Transient visual loss

Vestibular schwannoma

Combined third, fourth, and sixth nerve palsies

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and management

Differential diagnosis

Diagnostic workup

Media

References

Contributors

Authors

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Brain death/death by neurologic criteria

Hepatic encephalopathy

Bowel dysfunction in neurologic disorders

Coma due to primary brainstem and diencephalic lesions

Giant cell arteritis

Ischemic optic neuropathy

Transient visual loss

Vestibular schwannoma

This is an article preview.
Start a Free Account
to access the full version.